The January 2023 replay of past episodes showcases a selection of interviews covering a variety of topics in Autoimmune Neurologic Disorders. This episode features conversations with Dr. Marinos Dalakas on IVIg efficacy in GAD65 positive SPS patients , followed by an interview with Prof. Bart Jacobs about the association of preceding infections with the clinical variation of Guillain-Barré syndrome across geographical regions, leading into an interview with Prof. Sarosh Irani on the use of corticosteroids as a first-line agent in the treatment of LGI1-antibody encephalitis. January's Neurology Recall concludes with an interview with Dr. Ming Lim on the diagnosis and management of Opsoclonus Myoclonus Ataxia Syndrome (OMAS) in children. Associated Articles: Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody–Positive Stiff-Person Syndrome | Neurology Neuroimmunology & Neuroinflammation An International Perspective on Preceding Infections in Guillain-Barré Syndrome | Neurology Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis | Journal of Neurology, Neurosurgery & Psychiatry (bmj.com) Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children | Neurology Neuroimmunology & Neuroinflammation Disclosures can be found at Neurology.org.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related